462 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Article Searches
These 4 Vanguard ETFs Are All You Need for a Well-Rounded Stock Portfolio https://www.fool.com/investing/2024/10/18/these-4-vanguard-etfs-are-all-you-need-for-a-well/?source=iedfolrf0000001 Oct 18, 2024 - These ETFs give you exposure to companies from all size categories and abroad.
Netflix Q3: Launch Of In-House Advertising Platform By FY 2025 Bodes Well https://seekingalpha.com/article/4727510-netflix-stock-q3-launch-of-in-house-advertising-platform-by-fy25-bodes-well?source=feed_all_articles Oct 17, 2024 - We recommend a 'Strong Buy' on Netflix stock at $830/share, citing subscriber growth and upcoming ad platform. Read an investment analysis of NFLX stock here.
Wells Fargo (WFC) Q3 2024 Earnings Call Transcript https://www.fool.com/earnings/call-transcripts/2024/10/11/wells-fargo-wfc-q3-2024-earnings-call-transcript/?source=iedfolrf0000001 Oct 11, 2024 - WFC earnings call for the period ending September 30, 2024.
Wells Fargo & Company (WFC) Q3 2024 Earnings Call Transcript https://seekingalpha.com/article/4726269-wells-fargo-and-company-wfc-q3-2024-earnings-call-transcript?source=feed_sector_transcripts Oct 11, 2024 - Wells Fargo & Company (NYSE:WFC) Q3 2024 Earnings Conference Call October 11, 2024 10:00 AM ETCompany ParticipantsJohn Campbell - Director of IRCharlie...
Why JPMorgan Chase, Bank of America, and Wells Fargo Are Trading Higher https://www.fool.com/investing/2024/10/11/why-jpmorgan-chase-bank-of-america-and-wells-fargo/?source=iedfolrf0000001 Oct 11, 2024 - JPMorgan Chase and Wells Fargo reported third-quarter earnings this morning.
Capitulation in biotech is near, as well as a rally – Piper Sandler https://seekingalpha.com/news/4157929-capitulation-in-biotech-is-near-as-well-as-a-rally-piper-sandler?source=feed_sector_healthcare Oct 11, 2024 - Big amounts of selling in the healthcare-biotech sectors (XBI) could be signaling capitulation, followed by a rally, according to Piper Sandler.
Billionaires Are Deciding to Sell Shares of This Well-Known Stock https://www.fool.com/investing/2024/10/09/billionaires-are-deciding-to-sell-shares-of-this/?source=iedfolrf0000001 Oct 09, 2024 - This tech giant appears to look overvalued to some top investors.
CRH plc Is Well Positioned For Continued Growth In Infrastructure Spending https://seekingalpha.com/article/4725710-crh-plc-is-well-positioned-for-continued-growth-in-infrastructure-spending?source=feed_all_articles Oct 08, 2024 - CRH plc trades at a P/E of 16.31 and offers a solid dividend yield. Learn more about CRH stock and its potential for steady earnings growth.
Arcus a new overweight at Wells Fargo on potential of casdatifan in kidney cancer https://seekingalpha.com/news/4157111-arcus-new-overweight-wells-fargo-potential-casdatifan-kidney-cancer?source=feed_sector_healthcare Oct 08, 2024 - Wells Fargo initiates coverage of Arcus Biosciences with an outperform rating, citing best-in-class potential for renal cell carcinoma candidate casdatifan. Read more here.
How Well Do U.S. Treasury Yields Forecast Inflation? An Update Through September 30, 2024 https://seekingalpha.com/article/4725498-how-us-treasury-yields-forecast-inflation-update-through-september-2024?source=feed_all_articles Oct 07, 2024 - The total dollar returns for the 10, 20 and 30-year Treasury bonds have exceeded the returns for the 6-month T-bill money fund. Explore more details here.

Pages: 1...4567891011121314...47

<<<Page 9>